logo.jpg
Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference
28 mars 2024 08h15 HE | Processa Pharmaceuticals, Inc.
HANOVER, MD, March 28, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next...